JAK Inhibitor

JAK Inhibitors (62):

Cat. No.	Product Name	Effect	Purity

HY-N2515

Ginsenoside Rk1	Inhibitor	99.90%
Ginsenoside Rk1 is a unique component created by processing the ginseng plant (mainly Sung Ginseng, SG) at high temperatures.

HY-50856A

Ruxolitinib (S enantiomer)	Inhibitor	99.77%
Ruxolitinib S enantiomer is the S-enantiomer of Ruxolitinib.

HY-109148

Izencitinib	Inhibitor	≥98.0%
Izencitinib (TD-1473) is an orally active, non-selective and gut-restricted JAK inhibitor.

HY-111749

JAK-IN-4	Inhibitor
JAK-IN-4 is a prodrug of a JAK inhibitor, effective in murine collagen induced arthritis model.

HY-132849

Nezulcitinib	Inhibitor
Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor.

HY-150096

Zasocitinib	Inhibitor	98.02%
Zasocitinib (NDI-034858) is a TYK2 inhibitor, target TYK2 JH2 domain with binding constant K_d of <200 pM.

HY-100544

FLLL32	Inhibitor	99.78%
FLLL32, a synthetic analog of curcumina, is a JAK2/STAT3 dual inhibitor with anti-tumor activity.

HY-103018

Gusacitinib	Inhibitor	99.41%
Gusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC₅₀ values of 5-46 nM.

HY-N0705

Curculigoside	Inhibitor	99.73%
Curculigoside is the main saponin in C.

HY-100538

DTP3	Inhibitor	99.43%
DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor.

HY-N2409

Delphinidin chloride	Inhibitor	≥98.0%
Delphinidin chloride, an anthocyanidin, is isolated from berries and red wine.

HY-18303

AMG-47a	Inhibitor
AMG-47a is a potent and orally active lymphocyte-specific protein tyrosine kinase (Lck) inhibitor, with an IC₅₀ of 0.2 nM.

HY-111471A

JAK-IN-5 hydrochloride	Inhibitor	99.54%
JAK-IN-5 hydrochloride is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.

HY-109178

Ifidancitinib	Inhibitor	98.05%
Ifidancitinib (ATI-50002) is a potent and selective inhibitor of JAK kinases 1/3.

HY-107459

(E/Z)-AG490	Inhibitor	99.97%
(E/Z)-AG490 ((E/Z)-Tyrphostin AG490) is a racemic compound of (E)-AG490 and (Z)-AG490 isomers.

HY-109182

Lorpucitinib	Inhibitor	99.97%
Lorpucitinib is a Gut-Restricted JAK Inhibitor for the research of Inflammatory Bowel Disease.

HY-145588

Povorcitinib	Inhibitor	98.20%
Povorcitinib is a potent and selective inhibitor of JAK1.

HY-111471

JAK-IN-5	Inhibitor
JAK-IN-5 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.

HY-145588A

Povorcitinib phosphate	Inhibitor	98.36%

HY-139807

JAK-IN-14	Inhibitor	98.72%
JAK-IN-14 is a potent and selective JAK1 inhibitor, with an IC₅₀ of <5 μM.

Name
Email *

	Sorry, but the email address you supplied was invalid.